HotChillee Partners With Cure Leukaemia to Raise £500,000 | HOTCHILLEE

HotChillee Partners With Cure Leukaemia to Raise £500,000

 

Leading cycling events company HotChillee today confirmed a three-year partnership with Cure Leukaemia with the goal of raising half a million pounds. The money will be used to fund 10 new specialist research nurses at Centres across the UK to connect blood cancer patients with potentially life-saving or life-extending drugs that are not currently available through standard care.

 

As part of the programme HotChillee will deliver the third edition of the Cure Leukaemia London 2 Paris this September, supporting 150 riders on their epic 500km journey. In addition, HotChillee will provide entries to their premium global events to keen cyclists from Deutsche Bank, who launched a two-year national Charity of the Year partnership with Cure Leukaemia this year.

 

Former England, Crystal Palace and Wolves footballer, blood cancer survivor and Cure Leukaemia Patron Geoff Thomas fronted the charity’s two previous rides in 2015 and 2016. Geoff took up cycling after beating blood cancer in 2005 and has driven Cure Leukaemia’s move into major cycling events ever since he returned to the charity three years ago.

 

HotChillee Founder, Sven Thiele said: “We have worked with Geoff and his brilliant leukaemia fund raising initiatives several years ago and look forward to providing an event fundraising platform for this important cause over the next three years. Geoff, as a survivor is inspirational and I am certain that the £500k target will be exceeded with his active involvement!”

 

Geoff Thomas on the HotChillee LONDON-PARIS 2008

 

Geoff said: “I have known and worked with Sven and HotChillee for many years and the events they organise are of the highest quality. I know that their input will elevate an already superb London 2 Paris event and hopefully attract new supporters to Cure Leukaemia’s work. I am sure that, together, we will devise some really unique and memorable cycling events during these three years that will attract cyclists of all abilities and I am really looking forward to getting started!”

 

Cure Leukaemia CEO James McLaughlin said: “We are very excited to be partnering with such a highly-regarded cycling events company for the next three years. We are very confident that HotChillee’s input will make this year’s Cure Leukaemia London 2 Paris ride the most successful to date and we are looking forward to working closely with Sven and his team to maximise all opportunities from this and future events in the coming years.”

Places and sponsorship packages are available for Cure Leukaemia’s closed-road London 2 Paris event from September 20th-24th 2018. All-inclusive entry for this unforgettable event costs £1,200 – for more information and to book your place go to www.l2prevolution.com.

 

Cure Leukaemia London 2 Paris

 

About Cure Leukaemia

 

Founded in 2003 by Professor Charlie Craddock CBE and patients Graham Silk and Michael Woolley, Cure Leukaemia helps to bring pioneering drug and transplant treatments to blood cancer patients. The charity helps finance the internationally renowned Centre for Clinical Haematology at Queen Elizabeth Hospital in Birmingham, to fund life-saving, and sometimes world first, clinical trials to treat patients with blood cancer who have exhausted standard treatment options. To date, Cure Leukaemia has helped to treat over 4000 patients by leveraging over £25m worth of revolutionary drugs and funding crucial research nurses to administer these trials.

 

Without the expert research nurses to ensure patients are constantly monitored and cared for; these trials would not run and patients would miss the opportunity to access potentially life-saving therapies. The aim of Cure Leukaemia is to raise money to fund more research nurses and provide world-class treatment for its patients. Only by funding more nurses in more hospitals, can more blood cancer patients benefit from access to potentially life-saving treatment.

 

In 2017 Cure Leukaemia raised an additional £1m to fully fund the expansion of the Centre for Clinical Haematology. The transformational £3.4m project has doubled the Centre’s capacity for blood cancer patients treated, clinical trials opened and research nurses employed. Over 75 jobs will be created, and it will allow stem cell transplants to be performed as an outpatient for the first time. Not only will the Centre immediately increase the number of lives saved but also hasten global progress towards establishing effective treatments for all blood cancers within 25 years.

 

Thanks to a grant of over £2m from the Greater Birmingham and Solihull Local Enterprise Partnership (GBSLEP), work began on the Centre expansion in May 2017 and the Centre reopened in January 2018.

 

Also in 2017, Cure Leukaemia was selected to be one of Deutsche Bank’s Charities of the Year for 2018 and 2019, a partnership that could be worth at least £2m.